How to treat fungal acne — what it is, why it happens, and why regular acne products make it worse.

The term "fungal acne" is widely used but technically misleading. The condition it describes — Malassezia folliculitis — is not caused by the bacterium Cutibacterium acnes, which drives conventional inflammatory acne. It is caused by an overgrowth of Malassezia, a genus of yeast that lives naturally on almost all human skin. When Malassezia proliferates in the hair follicle, it causes an inflammatory reaction that produces small pustules that closely resemble acne. The treatment is entirely different.

Understanding this distinction matters practically: antifungal treatment resolves Malassezia folliculitis; conventional acne treatments (benzoyl peroxide, retinoids, antibiotics) do not — and in some cases, by altering the skin's bacterial environment, they can create conditions that allow the yeast to flourish further.

What Malassezia folliculitis looks like

The classic presentation is clusters of small, uniform, itchy pustules. They are usually 1–2mm in size and remarkably consistent in appearance compared to conventional acne lesions, which vary in size and type (comedones, papules, nodules, cysts). Malassezia folliculitis tends to be monomorphic — one type of lesion, similar sizes.

Location is a useful clue. Malassezia folliculitis typically appears on the chest, upper back, shoulders, and forehead — areas with a high density of sebaceous follicles and sebum production. Involvement of the cheeks or chin, the common sites for hormonal acne, is less typical. The itching is a particularly useful diagnostic sign: conventional acne pustules rarely itch; Malassezia folliculitis often does.

None of this is diagnostic with certainty. Definitive diagnosis requires a skin scraping examined under a microscope to identify the yeast. If treatment responses have been poor or uncertain, a dermatologist assessment is warranted before committing to a long treatment course.

Why it happens

Malassezia is lipophilic — it thrives on lipids, and the sebaceous follicle is a rich lipid environment. In conditions that increase local lipid availability, raise humidity on the skin surface, compromise the local immune environment, or alter the microbial balance, Malassezia can overgrow.

Humidity and occlusion are the most consistent triggers. Sweating heavily, living in a hot, humid climate, wearing occlusive clothing or sports equipment against the skin for extended periods — all of these create the warm, lipid-rich, humid follicular environment that Malassezia prefers.

Antibiotic use — topical or oral — is a significant trigger. Antibiotics reduce the bacterial populations that compete with Malassezia for nutrients and ecological space in the follicle. When the bacterial population falls, the yeast is free to expand. This is why courses of oral antibiotics for acne sometimes produce or worsen Malassezia folliculitis, and why the two conditions can coexist and be confused.

Skincare products rich in fatty acids can feed Malassezia. The yeast uses certain fatty acids — particularly oleic acid (C18:1) and linoleic acid (C18:2) — for growth. Products containing oils high in these fatty acids (olive oil, coconut oil, many seed oils) can worsen the condition on susceptible skin.

Immune compromise — from illness, corticosteroid use, or other factors — can allow the overgrowth to establish. People who are immunocompromised are at higher risk of more severe or widespread Malassezia folliculitis.

Treatment

The primary treatment is antifungal. Malassezia responds well to antifungal actives; it does not respond to antibacterial agents.

Topical antifungals are the first-line approach for mild to moderate presentations. Ketoconazole 2% shampoo, used as a leave-on face or body wash for a few minutes before rinsing, is a commonly recommended starting point. It is not a true skincare product, but as a temporary treatment it is effective. Selenium sulfide 1–2.5% shampoo is an alternative. Zinc pyrithione-containing products have milder antifungal activity and can support maintenance.

Prescription topical antifungals — ketoconazole 2% cream, clotrimazole, miconazole — are more directly effective than wash-off applications and are appropriate for facial presentations.

Oral antifungals (fluconazole, itraconazole) are typically reserved for widespread, resistant, or recurrent cases and require a prescription and medical supervision.

Treatment duration matters. Resolution usually requires 4–6 weeks of consistent antifungal use, and relapse is common when treatment is stopped without addressing the underlying triggers. A shorter maintenance phase — using an antifungal product less frequently after clinical resolution — can extend the result.

Adjusting skincare during treatment

Products containing fatty acids that Malassezia can use for growth are worth avoiding during an active flare. This means checking moisturisers, oils, and serums for oils high in oleic and linoleic acids: olive oil, sunflower oil, argan oil, rosehip oil, marula oil, and squalane (derived from olive) appear frequently in skincare. Not all of these are equally problematic, and the evidence linking specific fatty acid profiles to clinical flares is correlational rather than mechanistic — but removing them temporarily during treatment is low-risk and commonly recommended.

Ingredients that Malassezia cannot readily metabolise include mineral oil, isopropyl myristate derivatives, caprylic/capric triglycerides (fractionated coconut oil, which is high in saturated short-chain fatty acids rather than the unsaturated fatty acids Malassezia prefers), and dimethicone. Moisturisers based on these ingredients are generally considered Malassezia-safe.

Avoid heavy occlusive products over affected areas. Sweating without changing out of wet clothing promptly, and wearing non-breathable synthetic fabrics, both contribute to the environment the yeast prefers.

The Lux & Glo position

If a skincare routine that includes active acne products is not producing results — or is making breakouts worse — the diagnosis is worth reconsidering. Malassezia folliculitis is undertreated partly because it is underdiagnosed: the lesions look like acne, so people treat them as acne, with antibacterial products that don't address the actual cause.

An accurate diagnosis changes the treatment entirely. The foundation of any effective approach is resolving the underlying condition; skincare optimisation follows from that clarity, not before it.